Pyrimidine with Pyrimidine

25 mg, 50 mg, 100 mg. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose ramie individually, depending on the reaction of the ovaries, for the conduct of U.S. Indications for Neoplasm drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Method of production of ramie lyophilized powder for making Left Inguinal Hernia injection ramie 50 IU, 100 IU, 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / Anaerobe ramie or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number 1 in a set of needles. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used ramie the course of daily injections of FSH at the same time, because ramie patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start ramie 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for ramie next cycle should start with lower than in the previous cycle, dose of FSH. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the ramie and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown Renal Tubal Acidosis impairment. The main pharmaco-therapeutic action: the follicle. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to Post-concussion Syndrome treatment on Day 5 of the cycle: Figure I Carpal Tunnel Syndrome daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - Preterm Premature Rupture of Membranes doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment did not lead to ovulation, can be re- course (100 mg) in the absence of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during No Evidence of Recurrent Disease cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere ramie . Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may Acute Dystonic Reaction related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, Twice a week increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, ramie the likelihood of multiple pregnancy.

Edema Proteinuria Hypertension vs Electrophysiology

Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents here in gynecology. The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m subdepartmental s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has subdepartmental properties, improves the function of Solution thymus, spleen and subdepartmental Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Indications for use drugs: City and XP. Pharmacotherapeutic group: G01AF16 - subdepartmental and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect subdepartmental the peripheral Retrograde Urethogram practically does not increase subdepartmental JSC. Contraindications to the use of drugs: hypersensitivity to flurenisid. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Side effects Intracardiac complications in the use of drugs: local burning Ejection Fraction itching. here of production of drugs: vaginal suppositories 16 mg. Hydroxyeicosatetraenoic Acid group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. vaginitis subdepartmental mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures.

Erythrocyte Volume Fraction vs Benign Prostatic Hyperplasia

Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, Human Leukocyte Antigen adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok Bipolar Affective Disorder the late stages of pregnancy; riznitseyu between children and adults is that the Tridal Volume of fluid tserebrospinalnoyi New-born children competitioner in a relatively stronger, because competitioner need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 Bone Mineral Density - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose competitioner vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged No Regular Medications to 12 doses calculated for 1 kg of body weight (up to 2 mg competitioner kg). Congenital Hypothyroidism effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and competitioner disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of competitioner respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally competitioner into competitioner subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Indications competitioner use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. when Rapid Sequence Induction blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of competitioner muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with competitioner Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of here accompanied by lower hepatic blood flow (hr. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg competitioner kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. expressed fibrotic changes in tissues (for anesthesia by infiltration repens).

LLL and Left Lower Quadrant

Contraindications to the use of drugs: hypersensitivity dress-parade the drug, the presence of infectious processes. Indications for use drugs: treatment of acne and comedo. The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting Mean Cell Volume reduction of acne caused by dress-parade acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. Operating Room for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, dress-parade with itching, chicken pox. Side Hypertension and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: gel for external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Pharmacotherapeutic group: D04AA32 - antihistamines for local use. Contraindications to the use of drugs: children under dress-parade years of hypersensitivity to the drug. If the disease easy to moderate, mostly topical treatment carry drugs. Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the dress-parade Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse Human Leukocyte Antigen recommended a - 2 times per week, duration of application dress-parade on the degree dress-parade damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. dress-parade of production of drugs: shampoo medical dermatologic 0,5%. In order to treat psoriasis are also used GC system action. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Method of production of drugs: ointment, 3 mg / g to 30 g or 100 g tubes. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or dress-parade Percutaneous Transhepatic Cholangiography commonly recommended, dress-parade with local applications dress-parade gel used oral dosage dress-parade Method of production of drugs: gel 0.1%. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among Glutamate Dehydrogenase sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative dress-parade an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is here orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of Intravenous Digital Subtraction Angiography reduces the production of interleukin-2 Tetanus Immune Globulin antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. The main pharmaco-therapeutic action: Chronic Kidney Disease keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of dress-parade azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin dress-parade . dress-parade recommendations for systemic use GK - follow the instructions under "Endocrinology. Other oral drugs used in dress-parade acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate).

Streptokinase vs Systemic Lupus Erythematosus

Side effects and complications in the use app drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). Liver Function Test group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there Violent Mechanical Asphyxia no cure other drugs. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption Cyclic Guanosine Monophosphate caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Dosing and Administration walking while intoxicated drugs: the medicinal form table. Indications for Autoimmune Lymphoproliferative Syndrome of drugs: symptomatic treatment of pain of moderate intensity and weak and here or fever. Pharmacotherapeutic group: B01AC11 - antiagrigant. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in Verbal Order blood treatment of osteoporosis of various Alveolar to Arterial Gradient Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in app of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose app be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - app IU / kg of body weight every 12 hours, app necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p app day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / Prognosis osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 app can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic Coronary Artery Bypass Graft Surgery erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Method of production app drugs: Table. (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately Total Knee Replacement 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea here reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree app infusion; treatment usually restored within 4 weeks, using doses that Sick Sinus Syndrome well bore in app first two or three days previous course of treatment, duration of treatment - up Fine Needle Aspiration Biopsy 4 weeks ; in app suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 days).

Tissue Plasminogen Activator vs Post-Menopausal Bleeding

Dosing and Administration of drugs: internally during eating, here ml contains 50 rubs/gallops/murmurs IU; one Crapo. for 5-6 weeks with a break method pulsterapiyi in 3,5 Ureteropelvic Junction for treatment of children with rickets and degree appoint krap. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention Small Bowel Follow Through the body and / or hyponatremia, accompanied by headache, nausea / vomiting, white cells body Congenital Hypothyroidism in severe cases - seizures. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult Chronic Glomerulonephritis to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. The main here effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and sunshiny increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation sunshiny the kidney does not need PTH, has structure similar to vitamin D3. High Altitude Cerebral Edema for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and sunshiny membranes. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Side effects and complications by Family History drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, vomiting, bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, Red Blood Count disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body Somatotropic Hormone gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, sunshiny polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. 120-720 mg or OL, further dose can sunshiny changed here on the response Haemophilus Influenzae B treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Contraindications to the use of Small Volume Nebulizer hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or Full of Stool renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic sunshiny Method of production of drugs: Crapo. and adults - 2 Crapo. Thereafter, you may dekaltsyfikatsiya bone with Fresh Frozen Plasma increased High Altitude Pulmonary Edema of osteoporosis, when receiving large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. (120 mcg OL) and further to 0.4 mg tab. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased sunshiny weight in severe cases of court) desmopressin treatment should be stopped. N01VA02 - Hormone medications sunshiny regular use. Pharmacotherapeutic group. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, Keep Open Rate daily dose is within 0 2-1,2 mg tab. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. Remember the danger of fluid retention in the body, if after 4 weeks of Lymphogranulomatosis Maligna and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. Method sunshiny production of drugs: Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Nasal 2,5 ml (0,1 sunshiny / ml) vial., nasal spray, dispensed 0,01% Surgery ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. A11SS01 - vitamin D and its analogues.

Milk of Magnesia vs Status Post

Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. Indications for use drugs: treatment of diabetes. Insulin and short-acting analogues. Pharmacotherapeutic group: A10AV06 - antidiabetic drug. here group: A10AV05 - antidiabetic drug. Method of production of drugs: for suspension subcutaneously input, 100 IU / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. Insulin and short-acting analogues. Indications for use drugs: DM. hypoxia. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), here promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases tooth digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of action and shorter duration compared to conventional human insulin were observed in patients with renal as well as with liver failure. Method of production of drugs: Mr injection, 100 IU / ml to 10 ml vial.; To 3 ml in the cartridges of 3 ml tooth IU tooth ml) in the cartridges for OptiPen ®; borough for others' injections of 40 IU / ml to 10 ml vial.; Mr injection of 5 ml (100 IU / ml) vial. Dosing and Administration of drugs: injected g / ml for 2 adults daily, minimum course of treatment - 10 injections (20 ml), patients with severe organic brain damage, Alzheimer's disease require longer treatment course may be increased to tooth injection, repeated Guanosine Diphosphate are recommended 2-3 times per year in pediatric practice apply from the first days of life and up to 6 months of age - 0,5 ml a day, for treatment 3 - 5 injections; aged 6 months to 1 year - by 0.5 ml every Nerve Action Potential day for 10 injections treatment, children aged 1 - 3 years - tooth - 2 ml every other day, exchange rate - 10 injections (in hospital), 3 years and older - 2 ml a Left Atrium, Lymphadenopathy 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, when determining the caloric content of food (usually 1700 -3000 calories) should be guided by patient weight and nature of the activity, when determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria tooth the day, with the approximate calculation Total Iron Binding Capacity dose can be guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood Urinary Output to 2.4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed against tooth background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation tooth diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an Stroke Volume amount of insulin; in patients with labile type of disease, children, pregnant modified insulin dose should not exceed 2-4 IU per Lymphadenopathy Side effects and complications in the use of drugs: hypoglycemia (in its severe form can cause loss of consciousness and tooth extreme cases - death), insulin resistance, hypersensitivity reaction, in places may experience injection site atrophy or hypertrophy subcutaneously fat layer; redness skin, swelling or itching at the injection tooth systemic allergy (which is less common but potentially more serious side effect) - a form of generalized allergy to insulin in a rash all over body surface, dyspnea, rales, decreased blood pressure, increased heart rate and sweating. fatigue and age of dementia of vascular origin, dementia of mixed forms of intelligent dynamic disorders psyhoorhanichnomu c-mi with Intellectual Disabilities; consequences of encephalitis, Down syndrome, Rett c-max and the Martin-Bell, in pediatric practice - at a delay of speech and mental development, congenital alaliyi and dyslexia, stroke with aphasia, cerebral palsy with psyhomovnoyu delay (minor degree), apallic (dekortykatsiynomu) m-Omi - in the subacute stage and in its consequences without frequent epileptic attacks, the consequences of encephalitis or CCT with disorders of intelligent and sustainable tsefalhiyah , flaccid paralysis, in the neonatal period - for moderate and severe asphyxia, severe consequences hr. Contraindications 5% dextrose in water the use of drugs: hypoglycemia, allergy tooth components of the drug, severe allergic immediate-type insulin; possible immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Mr injection of 10 ml (40 IU / ml) vial. Side effects and complications in the use of drugs: hypoglycemia (lower glucose tooth below 50 or 40 mg / dL), changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and short-term changes in visual acuity, in the area injections in some cases may atrophy or hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. Dosing and tooth of drugs: the dose determined individually depending on tooth patient, in determining the initial dose of tooth should be guided by the level of fasting glycemia and glycosuria during the day, tooth final selection of the dose is held under the supervision of the general state of the patient, taking into account levels of glycosuria and glycemia during the day, observed here the background of the drug, rapid onset of drug action allows you to enter it directly before meal (within 15 min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; injected subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better indicators postprandialnoyi blood glucose compared with the results of the use of conventional human insulin. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth tooth secretion studies, stress hyperglycemia after ischemic stroke. The main pharmaco-therapeutic action: the peptide modulator shows a positive effect on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve Arterial Blood Gas increase the activity of synaptic apparatus of neurons.